Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Digital Health In Brief

This article was originally published in The Gray Sheet

Executive Summary

Congressman wants Office of Mobile Health at FDA. NIH seeks mHealth research partners. More digital health news.

You may also be interested in...



FCC-Appointed Task Force Seeks Public-Private Input In Growing U.S. mHealth Market

An mHealth Task Force appointed by Federal Communications Commission Chairman Julius Genachowski released a draft report Sept. 24 outlining ways federal agencies and private industry can help spur the adoption of mHealth technologies.

FDA Urged To Create mHealth Regulatory Office

FDA should establish a regulatory division specifically focused on mobile health products, an industry group recommends.

Darzalex Surpasses Stelara As J&J’s Best-Selling Drug

Sales of Stelara are expected to begin tapering off later this year when the first biosimilars launch in mid-2024 in Europe and later in the US.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT031596

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel